ID
9922
Description
Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Keywords
Versions (5)
- 3/5/15 3/5/15 -
- 3/9/15 3/9/15 -
- 4/23/15 4/23/15 -
- 12/15/15 12/15/15 -
- 9/17/21 9/17/21 -
Uploaded on
March 5, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Description
Adverse Event related to
Description
Cytarabine
Data type
integer
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C0010711
Description
Daunorubicin
Data type
integer
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C0011015
Description
Dasatinib
Data type
integer
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C1455147
Description
Underlying Disease
Data type
text
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C0277554
Description
Concomitant medication
Data type
text
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C2347852
Description
Other
Data type
integer
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- UMLS CUI-3
- C0205394
Description
Signature
Similar models
Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
C0678257 (UMLS CUI-2)
C0441800 (UMLS CUI-2)
C0877248 (UMLS CUI-2)
C0011008 (UMLS CUI-2)
C1519316 (UMLS CUI-2)
C0031831 (UMLS CUI-3)